Literature DB >> 6752361

Malignant histiocytosis presenting as lethal midline granuloma: immunohistological study.

K Aozasa, A Inoue.   

Abstract

Recent advances in immunology have revealed that the "histiocytic" lymphoma of Rappaport is a proliferation of transformed lymphocytes rather than true histiocytes, and that the malignant cells in malignant histiocytosis (MH) are truly transformed histiocytes. We previously reported cases of MH presenting as lethal midline granuloma (MH-LMG) utilising fresh tissue specimens for the detection of cytological markers in a small number of cases. The results showed the true histiocytic nature of the proliferating cells. In this study, paraffin-embedded specimens from 16 cases with MH-LMG were processed for immunoperoxidase procedures to confirm the true histiocytic nature of the proliferating cells. Five cases with nasal and paranasal lymphomas (ML) were also stained to test the usefulness of immunoperoxidase procedures for distinguishing the MH-LMG from ML. Results were as follows; proliferating cells in MH-LMG were histiocytic in nature, staining positive for lysozyme in MH-LMG in contrast to the negative staining in ML.

Entities:  

Mesh:

Year:  1982        PMID: 6752361     DOI: 10.1002/path.1711380306

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  3 in total

1.  Heterogeneous malignant non Hodgkin's lymphomas as a causative disorder in lethal midline granuloma.

Authors:  R H Laeng; H A Gerber; T Schaffner; K H Bürki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

2.  CT evaluation of polymorphic reticulosis.

Authors:  M M Teng; C Y Chang; W Y Guo; W Y Li; T Chang
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

Review 3.  Nasal NK/T-cell lymphoma: epidemiology and pathogenesis.

Authors:  Katsuyuki Aozasa; Tetsuya Takakuwa; Tadashi Hongyo; Woo-Ick Yang
Journal:  Int J Hematol       Date:  2008-02-08       Impact factor: 2.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.